Download PDF
Semin Respir Crit Care Med 2018; 39(03): 392-398
DOI: 10.1055/s-0038-1660474
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Surgical Management of Pulmonary Mycobacterial Disease

John D. Mitchell
1   Division of Cardiothoracic Surgery, University of Colorado School of Medicine, Aurora, Colorado
2   National Jewish Health, Denver, Colorado
› Author Affiliations
Further Information

Publication History

Publication Date:
02 August 2018 (online)

   Permissions and Reprints

Abstract

There is renewed interest in the use of adjuvant surgical resection in the treatment of pulmonary mycobacterial disease. For pulmonary Mycobacterium tuberculosis, the emergence of significant drug resistance has led clinicians to reconsider surgery in select cases, where a clear benefit in bacterial conversion and cure has been noted. Less data exist for the use of anatomic resection in the setting of pulmonary nontuberculous mycobacterial disease, although multiple reports have supported the use of surgery in select cases. Resection is generally well tolerated, and may often be performed through a minimally invasive approach. While medical treatment clearly remains the mainstay of therapy, more research is needed regarding the use of adjuvant resection in this patient population.

Keywords

drug-resistant tuberculosis - pulmonary nontuberculous mycobacterial disease - thoracic surgery - thoracoscopic surgery - bronchiectasis - cavitary lung disease
 

  • References

  • 1 Diacon AH, Pym A, Grobusch MP. , et al; TMC207-C208 Study Group. Multidrug-resistant tuberculosis and culture conversion with bedaquiline. N Engl J Med 2014; 371 (08) 723-732
    CrossrefPubMedSearch in Google Scholar
  • 2 Pym AS, Diacon AH, Tang SJ. , et al; TMC207-C209 Study Group. Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis. Eur Respir J 2016; 47 (02) 564-574
    CrossrefPubMedSearch in Google Scholar
  • 3 Pontali E, Sotgiu G, D'Ambrosio L, Centis R, Migliori GB. Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence. Eur Respir J 2016; 47 (02) 394-402
    CrossrefPubMedSearch in Google Scholar
  • 4 Gler MT, Skripconoka V, Sanchez-Garavito E. , et al. Delamanid for multidrug-resistant pulmonary tuberculosis. N Engl J Med 2012; 366 (23) 2151-2160
    CrossrefPubMedSearch in Google Scholar
  • 5 Skripconoka V, Danilovits M, Pehme L. , et al. Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis. Eur Respir J 2013; 41 (06) 1393-1400
    CrossrefPubMedSearch in Google Scholar
  • 6 Zumla AI, Gillespie SH, Hoelscher M. , et al. New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects. Lancet Infect Dis 2014; 14 (04) 327-340
    CrossrefPubMedSearch in Google Scholar
  • 7 Dara M, Sotgiu G, Zaleskis R, Migliori GB. Untreatable tuberculosis: is surgery the answer?. Eur Respir J 2015; 45 (03) 577-582
    CrossrefPubMedSearch in Google Scholar
  • 8 Kang M-W, Kim HK, Choi YS. , et al. Surgical treatment for multidrug-resistant and extensive drug-resistant tuberculosis. Ann Thorac Surg 2010; 89 (05) 1597-1602
    CrossrefPubMedSearch in Google Scholar
  • 9 Kim HJ, Kang CH, Kim YT. , et al. Prognostic factors for surgical resection in patients with multidrug-resistant tuberculosis. Eur Respir J 2006; 28 (03) 576-580
    CrossrefPubMedSearch in Google Scholar
  • 10 Chan ED, Laurel V, Strand MJ. , et al. Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med 2004; 169 (10) 1103-1109
    CrossrefPubMedSearch in Google Scholar
  • 11 Man MA, Nicolau D. Surgical treatment to increase the success rate of multidrug-resistant tuberculosis. Eur J Cardiothorac Surg 2012; 42 (01) e9-e12
    CrossrefPubMedSearch in Google Scholar
  • 12 Pomerantz BJ, Cleveland Jr JC, Olson HK, Pomerantz M. Pulmonary resection for multi-drug resistant tuberculosis. J Thorac Cardiovasc Surg 2001; 121 (03) 448-453
    CrossrefPubMedSearch in Google Scholar
  • 13 Vashakidze S, Gogishvili S, Nikolaishvili K. , et al. Favorable outcomes for multidrug and extensively drug resistant tuberculosis patients undergoing surgery. Ann Thorac Surg 2013; 95 (06) 1892-1898
    CrossrefPubMedSearch in Google Scholar
  • 14 Kir A, Inci I, Torun T, Atasalihi A, Tahaoglu K. Adjuvant resectional surgery improves cure rates in multidrug-resistant tuberculosis. J Thorac Cardiovasc Surg 2006; 131 (03) 693-696
    CrossrefPubMedSearch in Google Scholar
  • 15 Kempker RR, Vashakidze S, Solomonia N, Dzidzikashvili N, Blumberg HM. Surgical treatment of drug-resistant tuberculosis. Lancet Infect Dis 2012; 12 (02) 157-166
    CrossrefPubMedSearch in Google Scholar
  • 16 Marrone MT, Venkataramanan V, Goodman M, Hill AC, Jereb JA, Mase SR. Surgical interventions for drug-resistant tuberculosis: a systematic review and meta-analysis. Int J Tuberc Lung Dis 2013; 17 (01) 6-16
    CrossrefPubMedSearch in Google Scholar
  • 17 Fox GJ, Mitnick CD, Benedetti A. , et al; Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB. Surgery as an adjunctive treatment for multidrug-resistant tuberculosis: an individual patient data metaanalysis. Clin Infect Dis 2016; 62 (07) 887-895
    CrossrefPubMedSearch in Google Scholar
  • 18 Falzon D, Schünemann HJ, Harausz E. , et al. World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update. Eur Respir J 2017; 49 (03) 1602308
    CrossrefPubMedSearch in Google Scholar
  • 19 Griffith DE, Aksamit T, Brown-Elliott BA. , et al; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175 (04) 367-416
    CrossrefPubMedSearch in Google Scholar
  • 20 Jarand J, Levin A, Zhang L, Huitt G, Mitchell JD, Daley CL. Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease. Clin Infect Dis 2011; 52 (05) 565-571
    CrossrefPubMedSearch in Google Scholar
  • 21 Kang HK, Park HY, Kim D. , et al. Treatment outcomes of adjuvant resectional surgery for nontuberculous mycobacterial lung disease. BMC Infect Dis 2015; 15: 76
    CrossrefPubMedSearch in Google Scholar
  • 22 Mitchell JD, Bishop A, Cafaro A, Weyant MJ, Pomerantz M. Anatomic lung resection for nontuberculous mycobacterial disease. Ann Thorac Surg 2008; 85 (06) 1887-1892 , discussion 1892–1893
    CrossrefPubMedSearch in Google Scholar
  • 23 Shiraishi Y, Katsuragi N, Kita H, Hyogotani A, Saito MH, Shimoda K. Adjuvant surgical treatment of nontuberculous mycobacterial lung disease. Ann Thorac Surg 2013; 96 (01) 287-291
    CrossrefPubMedSearch in Google Scholar
  • 24 Yu JA, Pomerantz M, Bishop A, Weyant MJ, Mitchell JD. Lady Windermere revisited: treatment with thoracoscopic lobectomy/segmentectomy for right middle lobe and lingular bronchiectasis associated with non-tuberculous mycobacterial disease. Eur J Cardiothorac Surg 2011; 40 (03) 671-675
    PubMedSearch in Google Scholar
  • 25 Matsuoka K, Imanishi N, Matsuoka T, Nagai S, Ueda M, Miyamoto Y. Video-assisted thoracoscopic surgery for nontuberculous mycobacterial infection. Asian Cardiovasc Thorac Ann 2014; 22 (09) 1066-1071
    CrossrefPubMedSearch in Google Scholar
  • 26 Mitchell JD, Yu JA, Bishop A, Weyant MJ, Pomerantz M. Thoracoscopic lobectomy and segmentectomy for infectious lung disease. Ann Thorac Surg 2012; 93 (04) 1033-1039 , discussion 1039–1040
    CrossrefPubMedSearch in Google Scholar
  • 27 Tseng YL, Chang JM, Liu YS. , et al. The role of video-assisted thoracoscopic therapeutic resection for medically failed pulmonary tuberculosis. Medicine (Baltimore) 2016; 95 (18) e3511
    CrossrefPubMedSearch in Google Scholar
  • 28 Yen Y-T, Wu M-H, Lai W-W. , et al. The role of video-assisted thoracoscopic surgery in therapeutic lung resection for pulmonary tuberculosis. Ann Thorac Surg 2013; 95 (01) 257-263
    CrossrefPubMedSearch in Google Scholar
  • 29 Nahid P, Dorman SE, Alipanah N. , et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of drug-susceptible tuberculosis. Clin Infect Dis 2016; 63 (07) e147-e195
    CrossrefPubMedSearch in Google Scholar
  • 30 Aksamit TR, O'Donnell AE, Barker A. , et al; Bronchiectasis Research Registry Consortium. Adult patients with bronchiectasis: a first look at the US bronchiectasis research registry. Chest 2017; 151 (05) 982-992
    CrossrefPubMedSearch in Google Scholar
  • 31 Krasnov D, Krasnov V, Skvortsov D, Felker I. Thoracoplasty for tuberculosis in the twenty-first century. Thorac Surg Clin 2017; 27 (02) 99-111
    CrossrefPubMedSearch in Google Scholar
  • 32 Levin A, Sklyuev S, Felker I, Tceymach E, Krasnov D. Endobronchial valve treatment of destructive multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2016; 20 (11) 1539-1545
    CrossrefPubMedSearch in Google Scholar
  • 33 Alexander GR, Biccard B. A retrospective review comparing treatment outcomes of adjuvant lung resection for drug-resistant tuberculosis in patients with and without human immunodeficiency virus co-infection. Eur J Cardiothorac Surg 2016; 49 (03) 823-828
    CrossrefPubMedSearch in Google Scholar
  • 34 Shiraishi Y, Katsuragi N, Kita H, Tominaga Y, Kariatsumari K, Onda T. Aggressive surgical treatment of multidrug-resistant tuberculosis. J Thorac Cardiovasc Surg 2009; 138 (05) 1180-1184
    CrossrefPubMedSearch in Google Scholar
  • 35 Somocurcio JG, Sotomayor A, Shin S. , et al. Surgery for patients with drug-resistant tuberculosis: report of 121 cases receiving community-based treatment in Lima, Peru. Thorax 2007; 62 (05) 416-421
    CrossrefPubMedSearch in Google Scholar
  • 36 Yaldiz S, Gursoy S, Ucvet A, Kaya SO. Surgery offers high cure rates in multidrug-resistant tuberculosis. Ann Thorac Cardiovasc Surg 2011; 17 (02) 143-147
    CrossrefPubMedSearch in Google Scholar
  • 37 Koh WJ, Kim YH, Kwon OJ. , et al. Surgical treatment of pulmonary diseases due to nontuberculous mycobacteria. J Korean Med Sci 2008; 23 (03) 397-401
    CrossrefPubMedSearch in Google Scholar
  • 38 Nelson KG, Griffith DE, Brown BA, Wallace Jr RJ. Results of operation in Mycobacterium avium-intracellulare lung disease. Ann Thorac Surg 1998; 66 (02) 325-330
    CrossrefPubMedSearch in Google Scholar
  • 39 Watanabe M, Hasegawa N, Ishizaka A. , et al. Early pulmonary resection for Mycobacterium avium complex lung disease treated with macrolides and quinolones. Ann Thorac Surg 2006; 81 (06) 2026-2030
    CrossrefPubMedSearch in Google Scholar
  • 40 Shiraishi Y, Katsuragi N, Kita H, Tominaga Y, Hiramatsu M. Different morbidity after pneumonectomy: multidrug-resistant tuberculosis versus non-tuberculous mycobacterial infection. Interact Cardiovasc Thorac Surg 2010; 11 (04) 429-432
    CrossrefPubMedSearch in Google Scholar
  • 41 WHO Regional office for Europe. The role of surgery in the treatment of pulmonary TB and multidrug- and extensively drug-resistant TB. WHO Regional Office for Europe, Copenhagen; 2014
    PubMed
  • 42 Mitchell JD. Surgical approach to pulmonary nontuberculous mycobacterial infections. Clin Chest Med 2015; 36 (01) 117-122
    CrossrefPubMedSearch in Google Scholar